The Exposome Measuring Lifes Long Exposure

The Exposome Measuring Life’s Long Exposure

What the Blood Sample Cannot Yet Say

The year is 2050. A patient arrives for a routine medical visit and gives blood and urine, her postal code, and a short description of her lifestyle and habits. The clinic runs the samples through instruments that detect nutrients and pharmaceuticals she has taken, bacterial and viral infections she has had, and industrial chemicals she has encountered. Her postal code is cross-referenced against maps of air pollution, noise, and chemical release. Her genome is already on file. A clinician then tallies her unique disease risks — and the treatments most likely to slow, or even stop, what is coming. None of this is today’s practice. It is the future exposome researchers are working to create.

The word for it was coined in 2005 by Christopher Wild, a now-retired cancer epidemiologist at the International Agency for Research on Cancer in Lyon, France. [1] He described a “desperate need to develop methods with the same precision for an individual’s environmental exposure as we have for the individual’s genome.” [2] The genome had a map; the environment had a blur. The exposome — the sum of environmental exposures and lifestyle factors that, together with genetics, shape the risk of a person developing many common conditions, including cancer, heart failure, diabetes, and dementia — was, and largely remains, unmapped. Environmental exposures are estimated to account for between 70% and 90% of the risk of developing chronic disease. [1] “Genetics load the gun, but the environment pulls the trigger,” said Francis Collins, former director of the US National Institutes of Health. [1]

The gap Wild named is not a gap in effort. It is a gap in kind. A genome is a fixed sequence, readable in a single sample. An exposome is dynamic — a person’s chemical, microbial, dietary, and social exposures change by the hour, the season, the address. The blood draw in that 2050 clinic is not measuring exposure itself. It is measuring the residue and the traces that exposure leaves behind. “The signatures of past exposures stay in the body,” says Gary Miller, director of the Center for Innovative Exposomics at Columbia University. [1] Persistent organic pollutants leave their mark in blood lipids; tobacco smoke adds epigenetic markers to DNA that persist even in someone who has not smoked for 30 years. A single sample, though, rarely reconstructs the whole history: what entered and left the body across decades is partly inferred, partly lost.

Ana Maretti Garcia, a researcher at the University of Southern California, collects transcriptomics data from clusters of cells exposed to “forever chemicals” — the per- and polyfluoroalkyl substances that persist in the environment and in human tissue. [1] Her work sits at the sharp end of the problem: to know what a chemical does to a cell, you must first know which cells were exposed, at what dose, for how long, and in what company of other chemicals. Each of those variables is a measurement problem. Each measurement problem multiplies the others.

The Exposome Measuring Lifes Long Exposure (Image 1) — AI-generated image

The Stack of Problems

The technical barrier is not one barrier. It is a stack. At the bottom sits analytical chemistry: an instrument that has not been told what to look for can only report what it happens to detect. High-resolution mass spectrometry on blood or urine typically returns a spectrum with 10,000 to 100,000 distinct peaks, and working out which compounds correspond to those peaks is one of the field’s biggest bottlenecks. Machine-learning models can now sift through that data and decode it, and they can predict adverse biological effects from a chemical’s structure — a step toward folding as-yet-unknown chemicals into disease-risk assessments.

Above that sits the timing problem: a measurement taken today is a downstream echo of an exposure that may have occurred decades earlier, and it rarely reveals what the exposure was, when it happened, or how much of it reached the body.

Then there is the integration problem. Even if you could measure every chemical, every microbe, every nutrient, every noise event, every social stressor, you would have a dataset of such dimensionality that separating signal from noise is a research problem in its own right. Connecting all the dots — how that information translates into an individual’s disease risk — is, as Kyle Walsh of the US National Institute of Environmental Health Sciences puts it, “a data-analysis problem” — one that he says is becoming “much more tractable” with artificial-intelligence tools. [1] The capacity is also starting to exist: the Exposome-Scan facility in Leiden, the Netherlands, launched in 2024 to build exposome profiles for researchers and clinicians and can already identify roughly 700 chemicals, including pesticides and flame retardants — roughly 10% to 20% of the few thousand chemicals that drive significant exposures, says exposome researcher Roel Vermeulen. [1] At the NIH there is growing enthusiasm to fund a multi-year, multimillion-dollar Human Exposome Project. [1]

In March, Chirag Patel, an exposomics researcher at Harvard Medical School in Boston, Massachusetts, and his colleagues published one of the largest studies yet to match exposures with disease risks. [1] The team compared 619 markers of exposure, ranging from blood mercury content to vitamin B12 levels, with 305 measurable characteristics, including lung function and blood sugar level, using data from ten cohorts of the 55-year-running US National Health and Nutrition Examination Survey. [1] Taken individually, environmental exposures accounted for less than 1% of the variation in the measured outcomes, but that rose to an average of 3.5% when the researchers combined the effects of 20 exposures. [1] It might not seem like a large difference, but this figure rivals the predictive power of genetic variants that influence disease, and affirms the need to study real-life exposures to improve disease management, says Patel. [1] For example, 43% of participants’ triglyceride levels, a predictor of cardiovascular disease, were explained by a unique combination of 20 exposures — including trans fats and polychlorinated biphenyls. [1] Advanced cellular ageing — structural or molecular damage to cells — was most strongly associated with smoking, minimal physical activity, and exposure to heavy metals. [1] Not everyone is convinced the field is new. Some critics call exposomics a fresh label for environmental epidemiology, and others argue that the totality of a person’s exposures can never be measured. [1]

The Exposome Measuring Lifes Long Exposure (Image 2) — AI-generated image

The Exposome Measuring Lifes Long Exposure